News

Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care

The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.

Published on

Flyer Personalized cancer prevention

⇢ Registration is now open for those wishing to attend either in person in Villejuif or online.

Gustave Roussy and The Lancet have partnered to create the Lecture Series on Cancer Breakthroughs, a new programme of lectures dedicated to major advances in the fight against cancer. This annual event aims to bring together leading research, innovation and public health perspectives around the developments that are reshaping oncology.

The inaugural lecture of this partnership will take place on Friday 18 September at 5:00 pm in Villejuif. It will be delivered by Professor Timothy R. Rebbeck, an internationally renowned epidemiologist and specialist in personalised cancer prevention. Holder of the Vincent L. Gregory Chair in Cancer Prevention at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute, Professor Rebbeck’s work is helping to redefine prevention strategies in the era of precision medicine and has led to major advances in several fields, including:

  • Improving our understanding of cancer risks associated with BRCA gene mutations.

  • Demonstrating the effectiveness of preventive surgery for patients with a high genetic risk of cancer.

  • Investigating inequalities in prostate cancer risk and outcomes.. 

Programme

  • 5:00 pm. Introduction 

    • Vania Wisdom, The Lancet, United Kingdom.  

  • 5:10. Lecture by Professor Timothy R. Rebbeck - Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute, United States. 

  • 5:55 pm. Panel discussion

    • Professor Timothy R. Rebbeck, Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute, United States. 

    • Dr Judith Balmaña, Vall d’Hebron Institute of Oncology, Spain. 

    • Dr Suzette Delaloge, Institut national du cancer and Gustave Roussy, France. 

  • 6:40 pm. Q&A 

  • 7:00 pm. Closing remarks 

    • Vania Wisdom, The Lancet, United Kingdom.  

    • Professor Fabrice Barlesi, Gustave Roussy, France. 

A lecture exploring different aspects of cancer prevention

Professor Rebbeck’s lecture on 18 September will explore how advances in precision medicine are transforming the way cancer is approached.

For many years, efforts to combat cancer focused primarily on diagnosis and treatment once the disease developed. Today, by analysing genetic data, lifestyle factors, and environmental exposures, scientists can increasingly identify individuals at highest risk of developing certain cancers and intervene earlier, sometimes even before the first signs of disease appear.

The lecture will be followed by a panel discussion featuring, among others, Dr Judith Balmaña from the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona. An expert in inherited cancer predisposition, particularly breast and ovarian cancers associated with the BRCA1 and BRCA2 genes, her research focuses on the interpretation of genetic variants, PARP inhibitors, and Lynch syndrome. She has also contributed to several European clinical practice guidelines in the field of cancer genetics.

Practical Information

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin